Treatment
Share your love
NIH Elevates Emily Chew, MD, to Distinguished Investigator Status
Emily Chew, MD, has recently been elevated to the esteemed position of NIH Distinguished Investigator in recognition of her significant contributions as a care provider and clinical trialist. In her current role, Dr. Chew serves as the director of the…
Mantis Photonics Launches Eye Screening Crowdfunding
Mantis Photonics, at the forefront of space-inspired technology, announced the launch of a crowdfunding campaign for its seed round. This initiative, hosted on the Capital Cel platform, aims to fuel the development of Mantis Photonics’ noninvasive health screening technology using…
Promising Results for First Topical Treatment in DR
Exonate Ltd., a pioneering mRNA therapy company specializing in treatments for diabetic diseases, has announced that its lead ophthalmology asset, EXN407, successfully met prespecified endpoints in a phase Ib/IIa study for diabetic retinopathy and diabetic macular edema. During the trial,…
Nidek, Orbis Collaborate to Boost AI Eye Screenings in Vietnam
Nidek has pledged support to Orbis International through a donation aimed at enhancing artificial intelligence (AI) screening services in Vietnam. The donation comprises six specialized fundus cameras, designed to capture retina images, thereby aiding the expansion of Orbis’s AI-driven diabetic…
Researchers Develop Game-Changing Eye Drops for DME
After 30 years of dedicated work, two researchers have achieved a remarkable breakthrough by developing eye drops that can effectively reach the back of the eye. This groundbreaking development paves the way for needle-free treatments of blinding retinal diseases, such…
Vyjuvek Restores Vision in Teen with Rare Genetic Condition
Krystal Biotech’s topical gene therapy Vyjuvek (beremagene-geperpavec) has successfully restored the vision of a 13-year-old boy suffering from the rare genetic condition dystrophic epidermolysis bullosa (DEB), which scarred his eyes. The groundbreaking case, detailed in a recent publication in The…
Novel Protocol to Rapidly Diagnose Eye Stroke
Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai (NYEE) have pioneered a novel protocol aimed at swiftly diagnosing eye stroke and expediting care to prevent irreversible vision loss. Published in Ophthalmology, their study outlines the use of…
2023 Recap: Top 10 Acquisitions in the Ophthalmic Industry
In 2023, the ophthalmic industry witnessed a transformative landscape shaped by strategic company acquisitions, setting the stage for significant advancements and collaborations. The top 10 acquisitions of the year highlighted a dynamic shift in the competitive dynamics of the sector.…
Meridian Medical Introduces Ophthalmic Laser Line in US
Meridian Medical, headquartered in Switzerland, announced the launch of its line of ophthalmic lasers in the United States, following a series of FDA approvals. The FDA approval, received on January 25, includes the MR Q family of lasers, which offer…
Low-Dose Atropine Eye Drops & Myopia Progression
According to the National Eye Institute (NEI), a trial conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and funded by the NEI revealed that the use of low-dose atropine eye drops (concentration 0.01%) did not demonstrate superiority over a…